Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Daratumumab for newly diagnosed multiple myeloma: Pooled analysis of patients aged ≥65 years from GRIFFIN and PERSEUS
Paula Rodríguez‐Otero, Peter M. Voorhees, Mario Boccadoro, Jacob P. Laubach, Hermann Einsele, Douglas W. Sborov, Meletios A Dimopoulos, Annemiek Broijl, Roberto Mina, Andrew Spencer, Fredrik Schjesvold, Rebecca Silbermann, Francesca Gay, Luciano J. Costa, Aurore Perrot, Yanfang Liu, Jianping Wang, Anna Sitthi-Amorn, Robin Carson, Annelore Cortoos, Saad Z. Usmani, Paul G. Richardson, Philippe Moreau, Pieter Sonneveld, Jonathan L. Kaufman (2025). Daratumumab for newly diagnosed multiple myeloma: Pooled analysis of patients aged ≥65 years from GRIFFIN and PERSEUS. , 25(10), DOI: https://doi.org/10.1016/j.clml.2025.04.007.
Article21 days agoCharacterization of NDMM patients treated with daratumumab, lenalidomide, bortezomib and dexamethasone who fail to achieve a VGPR or have early progression
Jonathan L. Kaufman, Efstathios Kastritis, Nisha S. Joseph, Maria Gavriatopoulou, Lilly Gu, Craig C. Hofmeister, Vikas A. Gupta, Evangelos Terpos, Ajay K. Nooka, Sagar Lonial, Meletios A Dimopoulos (2025). Characterization of NDMM patients treated with daratumumab, lenalidomide, bortezomib and dexamethasone who fail to achieve a VGPR or have early progression. , 146(Supplement 1), DOI: https://doi.org/10.1182/blood-2025-407.
Article21 days agoAddition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
Meletios A Dimopoulos, Paul G. Richardson, Nizar J. Bahlis, Sebastian Grosicki, Michèle Cavo, Meral Beksaç, Wojciech Legieć, Anna Marina Liberati, Hartmut Goldschmidt, Andrew R. Belch, Hila Magen, Alessandra Larocca, Jacob P. Laubach, Maria Teresa Petrucci, Donna Reece, Darrell White, María‐Victoria Mateos, Ivan Špıčka, Mihaela Lazaroiu, Jesús G. Berdeja, Jonathan L. Kaufman, Ying‐Ming Jou, Alex Ganetsky, Mihaela Popa McKiver, Sagar Lonial, Katja Weisel, Meletios A Dimopoulos, Paul G. Richardson, Nizar J. Bahlis, Sebastian Grosicki, Michèle Cavo, Meral Beksaç, Wojciech Legieć, Anna Marina Liberati, Hartmut Goldschmidt, Andrew R. Belch, Hila Magen, Alessandra Larocca, Jacob P. Laubach, Maria Teresa Petrucci, Donna Reece, Darrell White, María‐Victoria Mateos, Ivan Špıčka, Mihaela Lazaroiu, Jesús G. Berdeja, Jonathan L. Kaufman, Ying‐Ming Jou, Alex Ganetsky, Mihaela Popa McKiver, Sagar Lonial, Katja Weisel, Irwindeep Sandhu, Monika Podhorecka, Antonio Palumbo, Adi Shacham‐Abulafia, Iuliana Vaxman, Ofer Shpilberg, Britta Besemer, Maurizio Martelli, Roberto Foà, Paolo de Fabritiis, Tommaso Caravita di Toritto, Emanuil Gheorghita, Albert Oriol, Philip Rowlings, Angelucci Emanuele, Angelo Michele Carella, Massimo Offidani, Joan Bladé, Luis Felipe Casado, Heather Oakervee, Victoria Panelli, Luís Meza, Thomas Kühr, Miguel Granell, Don Benson, Rajesh Nair, Viran Holden, J. N. Reeves, Richard Eek, Patricia Walker, John Catalano, András Rosta, Ewa Lech‐Marańda, Christy Samaras, Tony Reiman, Robert Weaver, Péter Ács, Andrew Grigg, Bernard De Prijck, Martha Louzada, Leonard Minuk, Michaël Sébag, Martine Klausmann, Manfred Welslau, Andrzej Hellmann, Catalin Danaı̈la, Pamela S. Becker, William Bensinger (2022). Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. , 9(6), DOI: https://doi.org/10.1016/s2352-3026(22)00103-x.
Article21 days agoAddition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
Meletios A Dimopoulos, Paul G. Richardson, Nizar J. Bahlis, Sebastian Grosicki, Michèle Cavo, Meral Beksaç, Wojciech Legieć, Anna Marina Liberati, Hartmut Goldschmidt, Andrew R. Belch, Hila Magen, Alessandra Larocca, Jacob P. Laubach, Maria Teresa Petrucci, Donna Reece, Darrell White, María‐Victoria Mateos, Ivan Špıčka, Mihaela Lazaroiu, Jesús G. Berdeja, Jonathan L. Kaufman, Ying‐Ming Jou, Alex Ganetsky, Mihaela Popa McKiver, Sagar Lonial, Katja Weisel, Meletios A Dimopoulos, Paul G. Richardson, Nizar J. Bahlis, Sebastian Grosicki, Michèle Cavo, Meral Beksaç, Wojciech Legieć, Anna Marina Liberati, Hartmut Goldschmidt, Andrew R. Belch, Hila Magen, Alessandra Larocca, Jacob P. Laubach, Maria Teresa Petrucci, Donna Reece, Darrell White, María‐Victoria Mateos, Ivan Špıčka, Mihaela Lazaroiu, Jesús G. Berdeja, Jonathan L. Kaufman, Ying‐Ming Jou, Alex Ganetsky, Mihaela Popa McKiver, Sagar Lonial, Katja Weisel, Irwindeep Sandhu, Monika Podhorecka, Antonio Palumbo, Adi Shacham‐Abulafia, Iuliana Vaxman, Ofer Shpilberg, Britta Besemer, Maurizio Martelli, Roberto Foà, Paolo de Fabritiis, Tommaso Caravita di Toritto, Emanuil Gheorghita, Albert Oriol, Philip Rowlings, Angelucci Emanuele, Angelo Michele Carella, Massimo Offidani, Joan Bladé, Luis Felipe Casado, Heather Oakervee, Victoria Panelli, Luís Meza, Thomas Kühr, Miguel Granell, Don Benson, Rajesh Nair, Viran Holden, J. N. Reeves, Richard Eek, Patricia Walker, John Catalano, András Rosta, Ewa Lech‐Marańda, Christy Samaras, Tony Reiman, Robert Weaver, Péter Ács, Andrew Grigg, Bernard De Prijck, Martha Louzada, Leonard Minuk, Michaël Sébag, Martine Klausmann, Manfred Welslau, Andrzej Hellmann, Catalin Danaı̈la, Pamela S. Becker, William Bensinger (2022). Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. , 9(6), DOI: https://doi.org/10.1016/s2352-3026(22)00103-x.
Article21 days agoClinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
Roberto Mina, Nisha S. Joseph, Francesca Gay, Efstathios Kastritis, Maria Teresa Petrucci, Jonathan L. Kaufman, Vittorio Montefusco, Maria Gavriatopoulou, Francesca Patriarca, Paola Omedè, Lawrence Boise, Μαρία Ρούσσου, Nicola Giuliani, Stefania Oliva, Massimo Offidani, Angelo Belotti, David L. Jaye, Lorenzo De Paoli, Evangelos Terpos, Sagar Lonial, Mario Boccadoro, Ajay K. Nooka, Meletios A Dimopoulos (2020). Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents. , 10(4), DOI: https://doi.org/10.1038/s41408-020-0307-4.
Article21 days ago